Search results
The Promise of Leadless Pacing
Author(s):
Katrina Mountfort
,
Reinoud Knops
,
Johannes Sperzel
,
et al
Added:
3 years ago
Article
Author(s):
Adryan A Perez
,
Frank W Woo
,
Darren C Tsang
,
et al
Added:
3 years ago
The use of cardiovascular implantable electronic devices (CIEDs) has increased dramatically, with approximately 1.2–1.4 million CIEDs implanted annually worldwide.1 In the US alone, there are more patients with CIEDs than registered nurses.2,3 CIEDs use leads that connect a generator to cardiac tissue to treat patients with many conditions including symptomatic bradycardia, morbid tachycardia…
View more
Author(s):
Klaus-Jürgen Gutleben
,
Henrik Fox
,
Thomas Bitter
,
et al
Added:
3 years ago
Implantable cardiac devices, such as pacemakers, are used to treat a number of heart conditions, especially those related to the electrical conduction system. Cardiac pacemakers are a well-established and effective therapy, and have been in use for more than 50 years.
The first pacemaker was implanted in a patient in October 1958 by Åke Senning in Stockholm, in cooperation with engineer Rune…
View more
Author(s):
Marco Schiavone
Added:
2 years ago
In this short interview recorded at EHRA 2022, Dr Marco Schiavone (Luigi Sacco University Hospital, Milan, IT) outlines the findings of a real-world meta-analysis designed to assess the clinical outcomes of S-ICD in HF patients from the largest European Registry. Results suggest that over 2 years, there were no significant differences in appropriate and inappropriate shocks between patients with…
View more
Author(s):
Leah M Raj
,
Leslie A Saxon
Added:
3 years ago
This study reviews how haemodynamic monitoring devices that provide indirect or direct measures of heart failure status relate to cardiac rhythm management devices for the management of patients with the condition. The role of patient-facing software and services that provide information from these devices to patients can create a new model of heart failure disease management. In this care…
View more
Added:
1 year ago
In this short interview Dr James V Freeman (Yale University School of Medicine, New Haven, CT, US) discusses the key findings from the study investigating in-hospital outcomes for Next-Generation Watchman FLX compared with Watchman Generation 2.5.
Discussion Points
Importance of this Study
Key Differences Between the Studied Devices
Study Design and Patient Baseline Characteristics
Key…
View more
Author(s):
Harish Manyam
,
Jitendra Singh Makkar
,
Peter Illes
,
et al
Start date:
Jun 30, 2021
View more
SICD vs TVICD: Exploring the Latest Evidence
Author(s):
Haran Burri
,
Pier D Lambiase
,
Jonathan Behar
,
et al
Added:
2 years ago
Video Series
Start date:
Apr 22, 2021
View more
ICE in LAAO
Author(s):
Juan Carlos Diaz
,
Mauricio Duque
,
Jorge Marin
,
et al
Added:
1 month ago
Article